Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:30:17 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 66.70 CHF | +3.41% |
|
+4.06% | +21.94% |
| 08-18 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-18 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 828M 1.02B 875M 751M 1.41B 97B 1.42B 9.84B 3.78B 49.35B 3.81B 3.73B 156B | P/E 2026 * |
16x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 678M 831M 716M 615M 1.15B 79.42B 1.16B 8.06B 3.1B 40.41B 3.12B 3.05B 128B | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.24x |
| Free-Float |
91.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| BSLN | Delayed | |
CBOE
| 0QNA | Real-time | |
|
Börse Stuttgart
| PK5 | Delayed | |
|
Boerse Muenchen
| PK5 | Real-time | |
|
London S.E.
| 0QNA | Delayed | |
|
OTC Markets
| BPMU.F | Delayed | |
|
Tradegate
| PK5 | Real-time | |
|
Deutsche Boerse AG
| PK5 | Delayed |
Last Transcript : Basilea Pharmaceutica AG
| 1 day | +3.41% | ||
| 1 week | +4.06% | ||
| Current month | +5.04% | ||
| 1 month | +28.27% | ||
| 3 months | +34.07% | ||
| 6 months | +26.33% | ||
| Current year | +21.94% |
| 1 week | 62.2 |  | 66.9 |
| 1 month | 52.7 | | 67.4 |
| Current year | 47.8 | | 67.4 |
| 1 year | 44.7 | | 67.4 |
| 3 years | 32 | | 67.4 |
| 5 years | 29.55 | | 67.4 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 2018-04-18 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 2019-04-09 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 2011-11-28 |
| Chairman | 71 | 2013-04-08 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/29/26 | Sell | -400 | 0.0030% | |||
| 5/13/26 | Sell | -1,043 | 0.0078% | |||
| 5/4/26 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.41% | +4.06% | +45.16% | +39.54% | 987M | |
| -0.71% | -6.35% | -4.87% | +9.03% | 46.05B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.59B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 42.35B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 38.86B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 32.24B | |
| +0.87% | -2.60% | - | - | 17.16B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.28B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.32B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.03B | |
| Average | +0.78% | -3.97% | +59.22% | +96.97% | 26.49B | |
| Weighted average by Cap. | +0.41% | -4.50% | +72.94% | +123.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 328M 282M 242M 454M 31.3B 457M 3.17B 1.22B 15.92B 1.23B 1.2B 50.31B | 275M 337M 290M 249M 467M 32.16B 469M 3.26B 1.25B 16.36B 1.26B 1.24B 51.7B |
| Net income | 68.7M 84.21M 72.55M 62.27M 117M 8.04B 117M 816M 314M 4.09B 316M 309M 12.93B | 51.82M 63.52M 54.73M 46.97M 88.12M 6.07B 88.57M 615M 237M 3.09B 239M 233M 9.76B |
| Net Debt | -150M -184M -158M -136M -255M -17.57B -256M -1.78B -685M -8.94B -691M -676M -28.25B | -214M -262M -226M -194M -363M -25.02B -365M -2.54B -976M -12.73B -984M -962M -40.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | CHF 66.70 | +3.41% | 50,394 |
| 26-09-10 | CHF 64.50 | -0.46% | 19,538 |
| 26-09-09 | CHF 64.80 | +0.47% | 21,467 |
| 26-09-08 | CHF 64.50 | +3.04% | 28,808 |
| 26-09-07 | CHF 62.60 | -2.34% | 29,816 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
